CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

JPMorgan Downgrades Fulcrum Therapeutics to Underweight From Overweight

Negative
AI Analysis

Summary

JPMorgan downgraded Fulcrum Therapeutics from Overweight to Underweight, reflecting a negative reassessment of the company's outlook.

Importance:4/10
Sentiment:
-0.70
analyst_downgraderating_change
Related Companies

Read the original article

Published by yahoo_finance on June 3, 2026 11:28 AM

Read Original